WHO ICTRP trial
Clinical Efficacy of Buxue Formula for Lower-risk Myelodysplastic Syndrome
ChiCTR2300070419 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300070419 |
|---|---|
| Public title | Clinical Efficacy of Buxue Formula for Lower-risk Myelodysplastic Syndrome |
| Scientific title | Clinical Efficacy of Buxue Formula for Lower-risk Myelodysplastic Syndrome |
| Primary sponsor | Guangdong Provincial Hospital of Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Myelodysplastic syndrome (MDS) |
| Interventions | Experimental group:Buxue Formula |
| Registration date | Apr 11, 2023 |
| Target size | Experimental group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: